Synapse Biomedical Revenue, Growth & Competitor Profile

DBA SYNAPSE BIOMEDICAL INC

Company Profile & Annual Report for Synapse Biomedical

Access the complete profile.

Synapse Biomedical Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	300 Artino St. Oberlin, OH 44074

Note: Revenues for privately held companies are statistical evaluations.


Synapse Biomedical's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Synapse Biomedical's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Synapse Biomedical is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Synapse Biomedical Annual Revenue and Growth Rate

Synapse Biomedical	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Synapse Biomedical's revenues are gauged from an analysis of company filings.

Synapse Biomedical's Income Statement (based on Industry Averages)

Synapse Biomedical P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Synapse Biomedical is developing and marketing. Synapse Biomedical doesn't have any recent trademark applications, indicating Synapse Biomedical is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SYNCHRONY Powered muscle stimulator system comprised of a stimulator, sensor, charger, and electrodes that provides contralaterally controlled functional electrical stimulation (CCFES) to improve the recovery of paretic limbs after stroke	06/08/2021
TRANSAERIS Muscle stimulation system for the diaphragm	04/18/2017
FRICTIONLOC Connector for medical electrode leads	04/18/2017

See all trademarks and details in the Full Report.

Market Share of Synapse Biomedical's Largest Competitors

A competitive analysis shows these companies are in the same general field as Synapse Biomedical, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Synapse Biomedical. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
STERIS	Mentor, OH	100
INVACARE	Elyria, OH	4
SYNAPSE BIOMEDICAL	Oberlin, OH	0
TROY INNOVATIVE INSTRUMENTS	Middlefield, OH	0
WILSON OPTICAL LABORATORIES	Mentor, OH	0
DAN ALLEN SURGICAL	Newbury, OH	0

Future Competition: Synapse Biomedical's Fastest Growing Competitors

These companies are in the same general field as Synapse Biomedical and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)